Syncona’s Nightstar Therapeutics to be bought by Biogen for $877 million
Nightstar Therapeutics has agreed to be acquired by Biogen.
Read More
Tag: ophthalmology
Novartis app allows ophthalmology patients to report data
Novartis has launched a new app that enables patients taking part in ophthalmic clinical trials to self-report data, which could potentially speed up the development of new therapies.
Read More
Bayer and Bradford Teaching Hospitals NHS FT open eye unit
Bradford Teaching Hospitals NHS Foundation Trust and Bayer have opened a new Macula Centre to expand and improve access to services for patients with wet Age-related Macular Degeneration (wet AMD), a leading cause of vision loss in adults.
Read More
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
